CLB - Latest News
Core Laboratories N.V. (CLB), operates in Energy / Oil & Gas Equipment & Services, trades on NYSE.
Market capitalization stands near $605.2M. Trailing twelve-month P/E ratio is 20.84. Beta to the broader market is 1.00.
The article list below shows the most recent CLB headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent CLB Headlines
Core Laboratories Q1 Earnings Meet Estimates, Decline Y/Y
zacks.com - May 4, 2026
CLB's Q1 earnings meet estimates but fall Y/Y as a revenue miss and Middle East disruptions weigh on both key segments.
Core Laboratories Inc. (CLB) Q1 2026 Earnings Call Transcript
seekingalpha.com - Apr 30, 2026
Core Laboratories Inc.
CORE LAB REPORTS FIRST QUARTER 2026 RESULTS
prnewswire.com - Apr 29, 2026
REVENUE OF $121. 8 MILLION, DOWN 12% SEQUENTIALLY AND FLAT YEAR-OVER-YEAR OPERATING INCOME OF $1.
DTI or CLB: Which Is the Better Value Stock Right Now?
zacks.com - Apr 29, 2026
Investors interested in Oil and Gas - Field Services stocks are likely familiar with Drilling Tools International Corp. (DTI) and Core Laboratories (
Core Laboratories to Post Q1 Earnings: Key Metrics to Watch
zacks.com - Apr 23, 2026
CLB heads into Q1 earnings with lowered guidance, geopolitical disruptions and cost pressures raising concerns over a potential earnings miss.
How News Affects CLB Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track CLB's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked CLB news questions
- What is the latest CLB news headline?
- The most recent CLB headline (May 4, 2026) is "Core Laboratories Q1 Earnings Meet Estimates, Decline Y/Y". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the CLB news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What CLB news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual CLB options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.